Delivery Order SPE2DB22D2218-SPE2DB24FR2RY
Award Date
6/4/24
Potential Completion Date
6/5/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,097,842 units of Amlodipine Besylate 10 mg tablets. The contract, worth $1,294.56, has a performance period through March 28, 2024 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,740.73 firm fixed-price delivery order is for the supply of 1,000 tablets of Amlodipine Besylate 5 mg, a medication used to treat high blood pressure and certain heart conditions. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,973.73, is for the delivery of Amlodipine-Valsartan 5-160 mg tablets, a medication used to treat high blood pressure and heart disease. The contract has a period of performance through February 5, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.00 delivery order contract is for the supply of AMLODIPINE-OLMESARTAN 5-20 MG 30S, a cardiovascular medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through January 2024, with no set-aside designation. Amerisourcebergen maintains a $999,999,999 IDC with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,164.51 firm fixed-price delivery order is for the supply of Amlodipine-Olmesartan 10-40 mg in 30-count packages. The contract has an ultimate completion date of April 17, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,101.54 firm fixed-price delivery order contract is for the supply of AMLODIPINE-OLMESARTAN 10-40 MG 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,194.39, is for the delivery of AMLODIPINE-VALSARTAN 10-160 MG 30S tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,437.87, is for the delivery of Amlodipine-Valsartan 10-320 mg tablets. This is a firm fixed-price delivery order contract with a completion date of February 13, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,789.20 firm fixed-price delivery order is for the supply of amlodipine-valsartan 5-160 mg tablets. The contract has an ultimate completion date of November 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,291.34 firm fixed-price delivery order is for the supply of AMLODIPINE-VALSARTAN 5-160 MG 30S, a cardiovascular medication, with a period of performance ending on November 1, 2024. This award is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...